Collectively, LINC00942 was demonstrated to promote HCC cell proliferation, inhibit ferroptosis, and trigger immunosuppression through regulating SLC7A11 in a m6A-dependent manner mediated by IGF2BP3 (Fig. 7). Here, LINC00942 is linked to hepatocellular carcinoma.